188 related articles for article (PubMed ID: 2801241)
1. Measurement of estrone-3-glucuronide and pregnanediol-3 alpha-glucuronide in early morning urine samples to monitor ovarian function.
Magini A; Pinzani P; Bolelli GF; Bassi F; Salerno R; Messeri G; Pazzagli M
J Biolumin Chemilumin; 1989 Jul; 4(1):567-74. PubMed ID: 2801241
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
3. Measurement of glucuronometabolites of 17 beta-estradiol and progesterone in diluted overnight urine. An approach to the study of luteal insufficiency.
Pazzagli M; Magini A; Forti G; Bolelli G; Scarselli G; Noci I; Pellegrini S; Rodbard D; Serio M
J Steroid Biochem; 1987; 27(1-3):399-404. PubMed ID: 3695488
[TBL] [Abstract][Full Text] [Related]
4. Ovarian function in premenopausal women affected by breast cancer: the measurement of glucuronoconjugate metabolites of 17 beta-estradiol and progesterone throughout one entire menstrual cycle.
Magini A; Pazzagli M; Salerno R; Simonis M; Mustacchi G; Serio M
J Steroid Biochem; 1990 Aug; 36(6):523-6. PubMed ID: 2214768
[TBL] [Abstract][Full Text] [Related]
5. Luteal phase estrogen is decreased in regularly menstruating older women compared with a reference population of younger women.
Mersereau JE; Evans ML; Moore DH; Liu JH; Thomas MA; Rebar RW; Pennington E; Cedars MI
Menopause; 2008; 15(3):482-6. PubMed ID: 18202592
[TBL] [Abstract][Full Text] [Related]
6. Determination of ovarian function using first morning urine steroid assays.
Denari JH; Farinati Z; Casas PR; Oliva A
Obstet Gynecol; 1981 Jul; 58(1):5-9. PubMed ID: 7195531
[TBL] [Abstract][Full Text] [Related]
7. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
[TBL] [Abstract][Full Text] [Related]
9. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
Adekunle AO; Collins WP; Whitehead MI
Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of using paper impregnated with urine instead of liquid urine for assessing ovarian activity.
Wasalathanthri S; Tennekoon KH; Sufi S
Ceylon Med J; 2003 Mar; 48(1):4-6. PubMed ID: 12795010
[TBL] [Abstract][Full Text] [Related]
11. Mean versus individual hormonal profiles in the menstrual cycle.
Alliende ME
Fertil Steril; 2002 Jul; 78(1):90-5. PubMed ID: 12095496
[TBL] [Abstract][Full Text] [Related]
12. Urinary beta-FSH subunit concentrations in perimenopausal and postmenopausal women: a biomarker for ovarian reserve.
Liu JH; Kao L; Rebar RW; Muse K
Menopause; 2003; 10(6):526-33. PubMed ID: 14627861
[TBL] [Abstract][Full Text] [Related]
13. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
[TBL] [Abstract][Full Text] [Related]
14. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
[TBL] [Abstract][Full Text] [Related]
15. Elevated urine estrogen and pregnanediol levels in daughters of breast cancer patients.
Trichopoulos D; Brown JB; Garas J; Papaioannou A; MacMahon B
J Natl Cancer Inst; 1981 Sep; 67(3):603-6. PubMed ID: 6944532
[TBL] [Abstract][Full Text] [Related]
16. The OVEIA assay, a simultaneous measurement of oestrone and pregnanediol glucuronides, for studying the treatment of infertility patients.
Anthony F; Aldrich C; Sharp NC; Smith EM; Masson GM; Dennis KJ
Hum Reprod; 1988 Oct; 3(7):870-2. PubMed ID: 3182977
[TBL] [Abstract][Full Text] [Related]
17. Multiple immunoassay: the simultaneous measurement of two urinary steroid glucuronides as an index of ovarian function.
Weerasekera DA; Kim JB; Barnard GJ; Collins WP
J Steroid Biochem; 1983 Apr; 18(4):465-70. PubMed ID: 6300555
[TBL] [Abstract][Full Text] [Related]
18. First-trimester rapid semiquantitative assay for urine pregnanediol glucuronide predicts gestational outcome with the same diagnostic accuracy as serial human chorionic gonadotropin measurements.
Long CA; Whitworth NS; Murthy HM; Bacquet K; Cowan BD
Am J Obstet Gynecol; 1994 Jun; 170(6):1822-5; discussion 1825-7. PubMed ID: 8203444
[TBL] [Abstract][Full Text] [Related]
19. The development of over-the-counter (OTC) assays for pregnanediol-3-glucuronide and estrone-B,D-glucuronide.
Bahar I
Prog Clin Biol Res; 1988; 285():139-51. PubMed ID: 3231643
[TBL] [Abstract][Full Text] [Related]
20. Comparison of endometrial biopsy and urinary pregnanediol glucuronide concentration in the diagnosis of luteal phase defect.
Miller MM; Hoffman DI; Creinin M; Levin JH; Chatterton RT; Murad T; Rebar RW
Fertil Steril; 1990 Dec; 54(6):1008-11. PubMed ID: 2245826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
